Exosomes are small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. They transfer DNA, RNA, and proteins to other cells, thereby altering the function of the targeted cells.

In recent years, exosomes have been gaining momentum as a strategy for accessing the therapeutic effects of cells without the risks and difficulties of administering cells to patients. With at least 41,103 scientific articles published about exosomes and at least 516 clinical trials, these small vesicles have intriguing potential to be used across a diverse range of therapeutic applications.

This database features all known companies worldwide who specialize in developing exosome and extracellular vesicle (EV) therapies, diagnostics, research tools, and platform technologies. 

It takes our team of analysts countless hours of exhaustive research to uncover these exosome and EV companies from across the globe, but thankfully, we have a talented and multilingual team who is up to the task.

We continually crowdsource feedback from our audience of nearly one million readers per year, as well as nearly one hundred thousand followers across our social media platforms.

As you can imagine, the quality of this database would not be possible without the past 19+ years of following this industry and developing proprietary datasets (to which AI crawlers do not have access).

This database exists because it is built on nearly two decades of granular tracking, proprietary datasets, and relationships from across the exosome landscape. 

If you want immediate and actionable insights from a trusted, U.S. based provider that specializes exclusively in cell therapy market insights, then this database is for you.